News | October 08, 2021
CDSCO approves Syntellix implants
This opens up a huge market for the company’s Magnezis implants in India
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
This product will be manufactured at Lupin’s Pithampur facility In India
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
The first clinical trial is expected to commence in early 2022 both in Europe and the US
Subscribe To Our Newsletter & Stay Updated
